Actinogen Limited

ASX:ACW ISIN:AU000000ACW3

 
 

News

Biotech Investors Move Ahead on the Learning Curve

🕔6/11/2015 3:13:43 PM 13289

Australian and New Zealand biotech investors are set to hear from a top line up of speakers from ASX-listed life science companies, as well as several private firms and international businesses, in July, at the 11th Bioshares Biotech Summit.

Read Full Article▸
###

1,858 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 7) (Last 30 Days: 36) (Since Published: 1858) 

Company Data

More News Results

  • 2025/06/30: ACW accesses up to $13.8m in non-dilutive R&D tax funding*
  • 2025/06/30: ACW 100th AD trial participant & interim analysis timeline*
  • 2025/06/16: ACW presents at BIO international partnering conference*
  • 2025/05/21: Ceasing to be a substantial holder*
  • 2025/05/19: Actinogen CMO presents positive depression data at APA 2025*
  • 2025/05/15: ACW Science Forum today - Preparing for commercialization*
  • 2025/04/30: Actinogen March 2025 quarterly activity report & Appendix 4C*
  • 2025/04/24: ACW Science Forum notice - Preparing for commercialization*
  • 2025/04/23: Change in substantial holding*
  • 2025/04/02: ACW CMO presents Xanamem pTau poster at ADPD25 conference*
*refer to company website